Stage D2 Prostatic carcinoma

Also known as: Stage D Prostate Cancer / Stage D2 Prostate cancer / Prostate cancer stage D / D Prostate cancer / Carcinoma of the prostate stage IV / Prostate cancer stage IV / Prostatic cancer stage IV

DrugDrug NameDrug Description
DB06719BuserelinA LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females.
DrugDrug NamePhaseStatusCount